Phase 4
Completed N=104
Treatment of Binge Eating in Obese Patients in Primary Care
Obesity · Binge Eating
Source: ClinicalTrials.gov NCT00537810 ↗
Enrolled (actual)
104
Serious AEs
0.0%
Results posted
Dec 2014
Primary outcomePrimary: Binge Eating (Remission) — 10; 8; 6; 6 participants — p=0.60
Summary
This study will test the effectiveness of two empirically-supported but distinct treatments for recurrent binge eating in obese patients: 1) Cognitive Behavior Therapy, using a pure self-help approach and 2) sibutramine, an anti-obesity medication also found to have efficacy for binge eating. Self-help Cognitive Behavior Therapy and sibutramine will be administered alone and in combination in a primary care setting.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Binge Eating (Remission) |
10; 8; 6; 6; 5; 11 | 0.60 |
| PRIMARY BMI |
38.4; 39.6; 35.9; 35.6 | — |
Eligibility Criteria
Inclusion Criteria
- Obese (BMI >= 30)
Exclusion Criteria
- Medication regimen that represents medical contraindication to sibutramine
- Serious unstable or uncontrolled medical conditions that represent contraindication to sibutramine
- Pregnancy
Data sourced from ClinicalTrials.gov (NCT00537810). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.